OnCore Login

Return to Trial Database

GU04-75

A Phase II Trial of Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer: Hoosier Oncology Group GU04-75

Status

Study Completed

Cancer Type(s)

Bladder

Study Contact

Publications

A Multicenter Phase II Study of Cisplatin (C), Gemcitabine (G), and Bevacizumab (B) As First-Line Chemotherapy for Metastatic Urothelial Carcinoma (UC)
  • NM Hahn, WM Stadler, RT Zon, D Waterhouse, J Picus, S Nattam, CS Johnson, SM Perkins, CJ Sweeney
Mature results from phase II trial of cisplatin (C), gemcitabine (G), and bevacizumab (B) as first-line chemotherapy for metastatic urothelial carcinoma (UC)
  • NM Hahn, WM Stadler, R Zon, DM Waterhouse, J Picus, SR Nattam, CS Johnson, SM Perkins, MJ Waddell, C Sweeney
Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab As First-Line Therapy for Metastatic Urothelial Carcinoma
  • NM Hahn, WM Stadler, RT Zon, D Waterhouse, J Picus, S Nattam, CS Johnson, SM Perkins, MJ Waddell, CJ Sweeney

Trial Locations

All sites in which the trial GU04-75 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278